Coronavirus as a Catalyst for Digitalisation and Public-Private Partnership in Medicine
The article focuses on the impact of the COVID-19 pandemic on digitalization and public-private partnerships (PPPs) in medicine. The epidemic of this disease has intensively affected Russia, and the viral economic crisis has highlighted the need for structural reforms in many sectors of the economy,...
Main Authors: | T. N. Yudina, A. M. Balashov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Government of the Russian Federation, Financial University
2021-03-01
|
Series: | Мир новой экономики |
Subjects: | |
Online Access: | https://wne.fa.ru/jour/article/view/312 |
Similar Items
-
Proactive and Strategic Healthcare Public-Private Partnerships (PPPs) in the Coronavirus (Covid-19) Epoch
by: David Baxter, et al.
Published: (2020-06-01) -
Protecting the emergency physician workforce during the coronavirus disease 2019 pandemic through precision scheduling at an academic tertiary care trauma center
by: Moon O. Lee, et al.
Published: (2021-02-01) -
A Coronavirus (COVID-19) Triage Framework for (Sub)National Public–Private Partnership (PPP) Programs
by: David Baxter, et al.
Published: (2020-06-01) -
The Innovative Medicines Initiative −10 Years of Public-Private Collaboration
by: Hugh Laverty, et al.
Published: (2019-12-01) -
Editorial: Public-Private Partnerships as Drivers of Innovation in Healthcare
by: Remco L. A. de Vrueh, et al.
Published: (2019-05-01)